Non-Myeloablative Allogeneic Stem Cell Transplantation

NCT00525876 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Rituximab
DRUG: Alemtuzumab
PROCEDURE: Allogeneic Stem Cell Infusion

Sponsor

M.D. Anderson Cancer Center